CAD 8.12
(-6.34%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 19.99 Million USD | 1279.78% |
2022 | 1.44 Million USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 170 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | -100.0% |
2000 | 55.23 Thousand USD | 8174479.68% |
1999 | 0.68 USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 6.65 Million USD | -73.2% |
2024 Q1 | 24.82 Million USD | 174.33% |
2023 Q3 | 6.18 Million USD | 94.65% |
2023 Q1 | 1.58 Million USD | 9.18% |
2023 Q2 | 3.17 Million USD | 100.82% |
2023 Q4 | 9.05 Million USD | 46.35% |
2023 FY | 19.99 Million USD | 1279.78% |
2022 Q4 | 1.44 Million USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 FY | 1.44 Million USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | -100.0% |
2021 Q1 | - USD | -100.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 170 Thousand USD | 0.0% |
2020 FY | 170 Thousand USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 Q2 | 0.03 USD | -95.84% |
2001 FY | - USD | -100.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | -100.0% |
2001 Q1 | 0.63 USD | -4.87% |
2000 FY | 55.23 Thousand USD | 8174479.68% |
2000 Q3 | 0.67 USD | 0.0% |
2000 Q4 | 0.67 USD | 0.21% |
1999 FY | 0.68 USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Appili Therapeutics Inc. | 813.74 Thousand CAD | -2356.912% |
Eupraxia Pharmaceuticals Inc. | -209.91 Thousand CAD | 9624.513% |
Helix BioPharma Corp. | -14 Thousand CAD | 142907.143% |
Microbix Biosystems Inc. | 7.48 Million CAD | -167.238% |
Medicenna Therapeutics Corp. | -5000.00 CAD | 399960.0% |
Satellos Bioscience Inc. | -8.81 Million CAD | 326.755% |
Oncolytics Biotech Inc. | -403 Thousand CAD | 5061.042% |
Sernova Corp. | -445.55 Thousand CAD | 4587.253% |